Article Per Year (5 Year)
p-Index From 2021 - 2026
1.288
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Farmasi Media Kesehatan Masyarakat Indonesia e-Journal Pustaka Kesehatan Media Farmasi : Jurnal Ilmu Farmasi (Journal Of Pharmaceutical Science) Jurnal Kesehatan Masyarakat (IKESMA) STOMATOGNATIC- Jurnal Kedokteran Gigi Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) Journal of Agropharmacy Journal of Pharmascience
Sinta Rachmawati
Fakultas Farmasi Universitas Jember
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Library & Information Science Materials Science & Nanotechnology Medicine & Pharmacology Public Health

Published : 12 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 12 Documents
Search

 1   2 
Evaluasi Perencanaan dan Pengadaan Obat dengan Dana JKN di Puskesmas Rambipuji Jember Norcahyanti, Ika; Firandi, Adelia; Ramadhani, Nuril Izzati Farihatur; Rachmawati, Sinta; Rachmawati, Ema; Aryani, Dhita Evi; Wardhani, Firdha Aprillia; Kusumaningrum , Yunita Dyah
Journal of Agropharmacy Vol. 1 No. 3 (2024)
Publisher : Faculty of Pharmacy, University of Jember

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.19184/joa.v1i3.1811

Abstract

Public Health Center is a health facility that organizes drug management activities, including planning and procurement activities. Evaluation needs to assess the success of achieving the objectives and results of the action. Indicators that can use are efficiency indicators published by the Ministry of Health of the Republic of Indonesia and efficiency indicators developed by Pudjaningsih. Rambipuji Public Health Center with spending funds for the most significant drug procurement in Jember Regency in 2020. Therefore, it is necessary to evaluate the results that can improve the quality of service in the next period. This research aims to determine the results of the evaluation of drug planning and procurement with JKN funds at Rambipuji Public Health Center for 2020. This research is descriptive, primary data through interview results. Secondary data includes total funds available, drug procurement funds, Drug Usage Reports, and Drug Demand Sheets for drugs purchased through JKN funds and stock cards. The data is analyzed descriptively, presented in the form of tables supported by interview results. The results showed that the Government of Indonesia had governed drug planning and procurement activities with JKN funds. The percentage indicator of available funds compared to the general funds needed is 114.26%. The percentage indicator of drug procurement fund allocation is 3.46%. Results on percentage indicator procurement conformity with the reality of the use of each drug item amounted to 133.33% and on the procurement frequency indicator of each drug item once a year. Through this research, it can be concluded that the evaluation results on indicators of the efficiency of drug planning and procurement activities at Rambipuji Public Health Center have not been by established standards. This matter was influenced by several factors, including a decrease in the number of patient visits due to the COVID-19 pandemic, changes in the organizational structure in the Jember Health Office that resulted in the frequency of procurement activities only once throughout 2020, and the absence of government regulations that regulate in more detail about the percentage of JKN funds allowed for drug procurement activities.
Profil Penggunaan Obat Off-Label pada Pasien Obstetri Ginekologi di RSUD Blambangan Banyuwangi Ika Norcahyanti; Sinta Rachmawati; Shafira Putri Pertiwi
Journal of Pharmascience Vol. 10 No. 2 (2023): Jurnal Pharmascience
Publisher : Universitas Lambung Mangkurat

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20527/jps.v10i2.17698

Abstract

Setiap obat yang beredar harus memiliki izin edar yang dikeluarkan dan disetujui oleh FDA atau lembaga yang berwenang seperti BPOM. Obat yang diresepkan, tetapi tidak sesuai dengan informasi resmi obat seperti indikasi, usia pasien, dan rute pemberian disebut sebagai off-label drug. Alasan suatu obat digunakan secara off-label diantaranya adalah obat tersebut memiliki lebih dari satu macam indikasi dan indikasi tersebut belum terdaftar atau belum mendapat persetujuan dari FDA. Penelitian ini bertujuan untuk mengetahui karakteristik pasien serta profil penggunaan off-label drug pada pasien obstetri ginekologi di RSUD Blambangan Banyuwangi. Penelitian ini merupakan penelitian retrospektif menggunakan catatan rekam medis pasien periode bulan Januari-Juni 2018. Sampel yang memenuhi kriteria inklusi sebanyak 233 orang pasien rawat inap. Pengolahan data dianalisis secara statistik deskriptif. Hasil penelitian menunjukkan bahwa pada karakteristik pasien didominasi oleh pasien dengan kelompok usia 20-35 tahun (64%), pasien dengan diagnosis dan tindakan partus section caesarean (44,2%), serta kelompok pasien BPJS (71,7%). Sedangkan pada profil penggunaan off-label drug didominasi oleh penggunaan misoprostol tablet (60,28%); asam traneksamat injeksi (20,57%); serta dexamethasone injeksi (17,38%) dengan kategori sebagai off-label indikasi. Melalui penelitian ini dapat disimpulkan bahwa penggunaan off-label drug pada pasien obstetri ginekologi di RSUD Blambangan Banyuwangi tetap didasarkan pada keuntungan dan manfaat dari setiap obat saat digunakan. Kata Kunci: Misoprostol, Asam Traneksamat, Deksametason, Partus Section Caesarean, Off-label Every drug must be issued a distribution permit that is approved by the FDA or an authorized agency such as BPOM. Medications prescribed for indications, patient age, and route of administration not accordance with the official information are referred to as off-label drugs. The reasons for using a drug off-label may include the drug having multiple indications or the indication has not been registered approved by the FDA. This study aimed to determine the characteristics of patients and the profile of off-label drug use in gynecological obstetrics patients at Blambangan Hospital. This retrospective study analyzed patient medical records from January-June 2018, and included 233 patients who met the inclusion criteria. Descriptive statistics were used for data analysis. The results showed that the patients age group of 20-35 years accounted for the majority (64%) of the sample, with a cesarean diagnosis (44.2%), and the BPJS patient group (71.7%). The off-label drug usage profile was primarily composed of misoprostol tablets (60.28%), tranexamic acid injection (20.57%) and dexamethasone injection (17.38%), all of which were used with the category of off-label indications. It can be concluded that the use of off-label drugs in gynecological obstetric patients at Blambangan Hospital was found to be based on the potential advantages and benefits of each drug when used.
Co-Authors Aryani, Dhita Evi Ema Rachmawati Fania Pratiwi Firandi, Adelia Hazrina, Inasa Ika Norcahyanti Inasa Hazrina Kusumaningrum , Yunita Dyah Machlaurin, Afifah Masito, Dewi Khurmi Pratiwi, Permata Sari Ramadhani, Nuril Izzati Farihatur Rizki Laili Fazeri Rustamaji Rustamaji Shafira Putri Pertiwi Sri Suryawati Wardhani, Firdha Aprillia Zaenudin, Mohamad Nor